Koss-Olinger Consulting’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Sell |
639
-23
| -3% | -$9.33K | 0.02% | 280 |
|
|
2025
Q1 | $329K | Buy |
+662
| New | +$329K | 0.03% | 248 |
|
|
2024
Q4 | – | Sell |
-531
| Closed | -$328K | – | 275 |
|
|
2024
Q3 | $328K | Hold |
531
| – | – | 0.03% | 216 |
|
|
2024
Q2 | $294K | Buy |
+531
| New | +$294K | 0.03% | 213 |
|
|
2024
Q1 | – | Sell |
-576
| Closed | -$306K | – | 281 |
|
|
2023
Q4 | $306K | Buy |
576
+11
| +2% | +$5.84K | 0.03% | 235 |
|
|
2023
Q3 | $286K | Sell |
565
-10
| -2% | -$5.06K | 0.04% | 196 |
|
|
2023
Q2 | $300K | Hold |
575
| – | – | 0.03% | 185 |
|
|
2023
Q1 | $331K | Sell |
575
-4
| -0.7% | -$2.3K | 0.04% | 166 |
|
|
2022
Q4 | $319K | Sell |
579
-22
| -4% | -$12.1K | 0.05% | 155 |
|
|
2022
Q3 | $305K | Buy |
601
+85
| +16% | +$43.1K | 0.05% | 152 |
|
|
2022
Q2 | $280K | Sell |
516
-77
| -13% | -$41.8K | 0.05% | 138 |
|
|
2022
Q1 | $350K | Sell |
593
-101
| -15% | -$59.6K | 0.06% | 137 |
|
|
2021
Q4 | $463K | Sell |
694
-58
| -8% | -$38.7K | 0.07% | 118 |
|
|
2021
Q3 | $430K | Sell |
752
-48
| -6% | -$27.4K | 0.07% | 129 |
|
|
2021
Q2 | $404K | Buy |
800
+53
| +7% | +$26.8K | 0.06% | 160 |
|
|
2021
Q1 | $341K | Buy |
+747
| New | +$341K | 0.06% | 163 |
|